Bachelor of Arts in Economics, University of California, San Diego; Member of the Global Entrepreneurship Leaders Program, PBC School of Finance, Tsinghua University; 2026 Fortune China 40 Under 40; 2025 Fortune China 40 Under 40 Most Promising Business Elite; First Batch of Young Investors, China Healthcare Investment H50; 2024 F40 China Young Investors by Zero2IPO; Initiated and deeply participated in the investment and exit of star projects including Healthgen Biotechnology, Asieris Pharmaceuticals, and Harbour BioMed; Formerly worked at the Asset Management Department of Guosen Securities.